Organizing Committee

Assistant Research Professor and group leader at the Cambridge Stem Cell Institute, where her lab studies how epigenetic regulation — particularly DNA methylation — shapes aging and age-related disease. She works to develop and validate biomarkers of aging and vice-chairs the 2026 Biomarkers of Aging Conference.

Faculty at the Stanford Stem Cell Institute and the Department of Obstetrics & Gynecology, and a member of the Biomarkers of Aging Consortium executive team. His research spans stem cell biology, epigenetics, and cellular reprogramming, with a focus on understanding and reversing age-related change.

Investigator at Brigham and Women’s Hospital and Instructor in Medicine at Harvard Medical School, and a co-founder of the Biomarkers of Aging Consortium. His research in the Gladyshev Lab focuses on the fundamental nature of aging and how biological age can best be measured; he also co-chairs the ARDD meeting.

Co-founder of Longevity Global and Boston Longevity Week, where he serves as VP of Communications and Boston Chapter Lead. He works to connect the city’s longevity researchers, investors, and entrepreneurs and to grow Boston’s healthy-longevity community.

Founder and Executive Director of Longevity Global and CEO and co-founder of NeuroAge Therapeutics. An MIT-trained neuroscientist with an MD/PhD from the University of Pittsburgh, she pioneered aging clocks of the human brain and lectures at MIT, Boston University, and NYIT.